# DESCRIPTION

## FIELD OF THE INVENTION

- relate to mosquito control compounds and compositions

## BACKGROUND OF THE INVENTION

- motivate need for new mosquito control strategies
- describe current understanding of mosquito biology
- discuss limitations of current control methods
- highlight importance of identifying new protein targets
- summarize prior art in mosquito eggshell formation

## SUMMARY OF THE INVENTION

- introduce compositions and methods for mosquito control
- describe compounds that reduce expression of target genes
- identify target genes including EOF1, Nasrat, Closca, Polehole, Nudel, CATL3, DCE2, D
- describe functional nucleic acids as compounds
- describe gene editing compositions as compounds
- introduce protease inhibitors as compounds
- describe biotic or abiotic systems for compound delivery
- outline methods for contacting mosquito cells with compounds
- describe methods for reducing transmission of diseases
- introduce methods for identifying mosquito-specific target genes
- introduce methods for identifying inhibitors of target proteins

## DETAILED DESCRIPTION OF THE INVENTION

### I. Definitions

- define isolated
- define nucleic acid
- define polynucleotide
- define gene
- define nucleic acid molecule encoding
- define heterologous
- define homologous
- define autologous
- define endogenous and exogenous
- define recombinant protein and DNA
- define polypeptides and variants

### II. Compositions

- introduce EOF1 protein and its role in eggshell melanization and embryonic development
- describe compositions and methods for reducing EOF1 gene or gene product
- describe inhibitors of EOF1 gene or gene product
- introduce other proteins important for eggshell melanization and embryonic development
- describe compositions and methods for reducing Nasrat, Closca, Polehole, Nudel, CATL3, DCE2, DCE
- describe inhibitors of Nasrat, Closca, Polehole, Nudel, CATL3, DCE2, DCE4, or
- describe typical inhibitors of target genes/gene products
- describe functional nucleic acids as inhibitors
- describe gene editing compositions as inhibitors
- describe EOF1 genes and gene products
- provide sequences of EOF1 genes and gene products
- describe other target genes and gene products
- provide sequences of other target genes and gene products
- describe identifying homologues of target genes/gene products
- describe using accession numbers to identify homologues
- describe inhibitors of target genes/gene products
- describe functional nucleic acids as inhibitors of target genes/gene products
- describe specific types of functional nucleic acids (antisense, ribozymes, external guide sequences)
- introduce RNA interference
- describe mechanism of RNA interference
- describe siRNA
- describe production of siRNA
- describe vectors for in vivo expression of functional nucleic acids
- introduce gene editing compositions
- describe CRISPR/Cas system
- describe elements of CRISPR system
- describe guide RNA
- describe zinc finger nucleases
- describe DNA-binding domain of zinc finger nucleases
- describe transcription activator-like effector nucleases
- describe DNA-binding domain of TALENs
- describe gene altering polynucleotides
- describe repair of double strand breaks
- describe applications of genome editing compositions
- define triplex forming oligonucleotides
- describe properties of triplex forming molecules
- introduce oligonucleotide composition
- describe nucleic acid bases
- discuss modified nucleotides
- describe heterocyclic bases
- discuss sugar modifications
- introduce morpholino oligonucleotides
- describe internucleotide linkages
- introduce locked nucleic acids and peptide nucleic acids
- define protease inhibitors
- describe types of protease inhibitors

### III. Methods of Use

- inhibit target genes/gene products
- introduce functional nucleic acid/gene editing composition
- reduce expression/activity/bioavailability of target gene/gene product
- induce physiologic/phenotypic effects in mosquitoes
- prevent spread of mosquito-borne illnesses
- genetically manipulate mosquitoes
- administer functional nucleic acid/RNAi
- modify genes in mosquitoes using CRISPR/Cas9
- use gene drive systems to reduce egg development/fitness
- formulate pesticide compositions
- include delivery vehicle to enhance stability/transfectability
- incorporate compound into nanoparticle/microparticle
- add other ingredients to aid in application of compound
- describe compound composition
- list surfactants
- describe carriers and diluents
- specify amounts of carriers and diluents
- introduce methods of administration
- describe delivery methods
- list application sites
- describe RNAi delivery systems
- discuss nucleic acid composition efficacy
- describe gene silencing methods
- specify target genes and products
- describe timing of compound administration
- list diseases to be treated
- list target mosquito species
- describe EOF1 role in mosquito eggshell development
- discuss target genes and mosquito species

### IV. Kits

- package compositions for pest control

### V. Screens for Mosquito-Specific Genes

- identify mosquito-specific genes in silico
- validate gene targets using functional nucleic acids

### VI. Screens for Enzyme Inhibitors

- identify inhibitors of target proteins using screens
- express and purify recombinant protein
- determine enzyme activity and substrate specificity
- screen small molecule libraries for inhibitory molecules
- validate promising inhibitory molecules in secondary screens
- evaluate effect of inhibitors on target protein activity and eggshell phenotypes

## EXAMPLES

### Example 1: EOF1 is an Important Protein for Viable Embryos

- introduce mosquito rearing
- describe mosquito-specific gene identification
- outline dsRNA synthesis and microinjection
- detail mosquito egg hatching assay
- describe bleach assay
- perform statistical analysis
- present results of RNAi screening
- characterize EOF1 protein
- analyze eggshell formation and melanization
- investigate EOF1 function in egg development
- discuss RNAi-EOF1 effect on egg viability

### Example 2: EOF1 Expression Pattern

- describe EOF1 gene expression by qPCR
- prepare enriched mosquito eggshell
- perform SDS-PAGE and Western Blot analysis
- conduct fluorescence in situ hybridization
- measure RNAi-EOF1 knockdown efficiency
- present results of EOF1 expression pattern

### Example 3: Follicle Development in EOF1-Deficient Females

- describe apoptosis assay for ovarian follicles
- perform Rhodamine B and Neutral Red mosquito follicle permeability assay
- present results of follicle development in EOF1-deficient females

### Example 4: Ultrastructure Analysis of Mosquito Eggs

- introduce mosquito eggshell ultrastructure study
- describe SEM analysis of ovarian follicles
- discuss effects of RNAi-EOF1 on eggshell formation
- propose explanation for aberrant eggshell melanization
- discuss role of EOF1 in eggshell development
- summarize findings on EOF1 function in Ae. aegypti and Ae. albopictus

### Example 5: Nasrat, Closca, Polehole and Nude1 are Important Eggshell Proteins

- introduce RNAi screen for eggshell proteins
- describe in vitro follicle melanization assays
- discuss effects of RNAi against Nasrat, Closca, Polehole, and Nude1
- analyze eggshell protein expression in response to RNAi-EOF1
- investigate tissue-specific expression of Nasrat, Closca, Polehole, and Nude1
- examine effects of RNAi-Nude1 on eggshell melanization and viability
- discuss role of Nude1 serine protease in eggshell melanization
- investigate effects of protease inhibitors on eggshell melanization
- analyze follicle permeability in response to RNAi-Nasrat, -Closca, -Polehole, and -Nude1
- propose three-stage model for eggshell formation and melanization
- discuss involvement of specific proteins in eggshell melanization and cross-linking
- contemplate use of small inhibitory molecules to control mosquito populations

